TheraRadar
Data updated: May 26, 2026

DESOXIMETASONE

Corticosteroid Hormone Receptor Agonists
Dermatology Approved 1998-04-01

DESOXIMETASONE is indicated for the treatment of Dermatoses.

Source: FDA Label • RISING
Jump to: Indications Approvals Trials Competitors Similar Safety Patents
30
Indications
--
Phase 3 Trials
28
Years on Market

Details

Status
Prescription
First Approved
1998-04-01
Routes
TOPICAL
Dosage Forms
OINTMENT, CREAM, GEL, SPRAY

Companies

RISING ZYDUS LIFESCIENCES COSETTE Teva PADAGIS US PADAGIS ISRAEL SCIEGEN PHARMS Lupin FOUGERA PHARMS THE J MOLNER EPIC PHARMA LLC ALTANA GLENMARK PHARMS LTD NOVEL LABS INC PAI HOLDINGS PHARM
Active Ingredient: DESOXIMETASONE

DESOXIMETASONE Approval History

1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Original
New Indication
New Form
Label Update
36 FDA actions from 1998 to 2026
Mar 2026 SUPPL
Mfg · Manufacturing (CMC)
Mar 2025 SUPPL
Mfg · Manufacturing (CMC)
Aug 2023 SUPPL
Label · Labeling

What DESOXIMETASONE Treats

1 indications

DESOXIMETASONE is approved for 1 conditions since its original approval in 1998. These indications span multiple therapeutic areas including oncology, immunology, and more.

  • Dermatoses
Source: FDA Label

DESOXIMETASONE Competitive Set

Pro

Three rings of competition based on shared molecular targets and treated indications.

Indication competitors

10

Same indication, different mechanism — what else might this patient receive?

HALOBETASOL PROPIONATE AND TAZAROTENE
SUN PHARMA
2025 1 indic.
CLOCORTOLONE PIVALATE
TARO
2020 1 indic.
Unlock 8 more competitors across all three rings.
Upgrade to Pro

Filters applied: drops same-active-ingredient (505(b)(2) reformulations), route-mismatch (topical vs systemic), and cross-therapeutic-area matches in same-indication rings.

Drugs Similar to DESOXIMETASONE

3 of 20

FDA-approved drugs for similar conditions. Compare mechanisms and indications to understand treatment alternatives.

ALA-SCALP
HYDROCORTISONE
1 shared
LEGACY PHARMA
Shared indications:
Dermatoses
ALCLOMETASONE DIPROPIONATE
ALCLOMETASONE DIPROPIONATE
1 shared
SUN PHARMA CANADA
Shared indications:
Dermatoses
AMCINONIDE
AMCINONIDE
1 shared
TARO PHARM INDS
Shared indications:
Dermatoses
View all 20 similar drugs Pro
🔬

Active Pipeline

Pro

Ongoing clinical trials by development phase

Loading...
⭐

Key Completed Trials

Pro

Completed studies with published results, ranked by significance

Loading...
📊

Trial Timeline

ClinicalTrials.gov ↗ Pro

Full development history with FDA approval milestones

|
Loading...
Understanding FDA Approval Types
Count Type What it means
- ORIG Original approval - drug first enters market
- SUPPL - Efficacy New indication (new disease/condition approved)
- SUPPL - Labeling Label text changes (warnings, dosing updates)
- SUPPL - Manufacturing Production changes (new facility)
- SUPPL - Chemistry Formulation changes (new dosage strength)

Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.

DESOXIMETASONE FDA Label Details

Indications & Usage

DESOXIMETASONE is indicated for the treatment of Dermatoses.

Looking for the branded version?

TOPICORT

Full clinical data, patents, trials, and competitive landscape for desoximetasone.

See TOPICORT

Data Sources

FDA Approval: ANDA204272 → Label: DailyMed → Trials: ClinicalTrials.gov →

Data sourced from official FDA and NIH databases. Click links to verify on original sources.